SolidTumorCheck+ is an advanced lab test by PreCheck Health that utilizes cutting-edge next-generation targeted sequencing to identify and target abnormalities within tumors. This test capture DNA and RNA technology, Single Nucleotide Variants (SNVs), Insertions/deletions (INDELs), Copy Number Variants (CNVs), splice variants, and fusions in solid tumors.
It sequences over 500 genes known to be relevant to cancer treatment and assesses essential immunotherapy (IO) biomarkers, providing oncologists with a comprehensive view to devise tailored treatment plans for their patients.
We believe in the potential of genomics to transform human health, and are working to ensure that communities anywhere can experience the benefits.
It sequences over 500 genes known to be relevant to cancer treatment and assesses essential immunotherapy (IO) biomarkers, providing oncologists with a comprehensive view to devise tailored treatment plans for their patients. Genomic Testing that Facilitates the Identification and Treatment of Cancer.
500+ solid tumor related genes with broad coverage of key guidelines and clinical trials for multiple solid tumor types.
You can expect results in approximately three weeks, facilitated by either manual or automated workflows that encompass library preparation, sequencing, and data analysis.
Sensitivity of 98.91% Specificity >99.99% using Orthogonal methods, Including DNA and RNA. Accurately measures TMB, MSI, SNVs, INDELs, CNVs, structural variations, and gene fusions.
Comprehensive Pan-Cancer Panel High-Throughput includes key guideline biomarkers for multiple cancer types, plus pan-cancer biomarkers such as MSI, NTRK1-3, and TMB.
AKT1, ALK, BRAF, DDR2, EGFR, ERBB2, FGFR1, FGFR3, KRAS, MAP2K1, MET, NRAS, PIK3CA, PTEN, RET, TP53
BRAF, CTNNB1, GNA11, GNAQ, KIT, MAP2K1, NF1, NRAS, PDGFRA, PIK3CA, PTEN, TP53
AKT1, BRAF, HRAS, KRAS, MET, MLH1, MSH2, MSH6, NRAS, PIK3CA, PMS2, PTEN, SMAD4, TP53
BRAF, BRCA1, BRCA2, KRAS, PDGFRA, FOXL2, TP53
AKT1, AR, BRCA1, BRCA2, ERBB2, FGFR1, FGFR2, PIK3CA, PTEN
BRAF, KIT, KRAS, MET,MLH1, PDGFRA, TP53
MSH6, PMS2, TSC1
ALK, APC, BRAF, CDK4, CTNNB1, ETV6, EWSR1, FOXO1, GLI1, KIT, MDM2, MYOD1, NAB2, NF1, PAX3, PAX7, PDGFRA, PDGFRB, SDHB, SDHC, SMARCB1, TFE3, WT1
Advanced interpretation technology to deliver timely and more accurate variant identification.
Relevant treatment options and the most precise clinical results, all in a physician-ready report. This technology is backed by a comprehensive knowledge-base and a powerful rules engine that takes many disparate inputs from our knowledge- base and distills them into concise interpretations and connections supporting evidence.
With over 350,000 rules in place, characteristics of patient variants are leveraged to surface the most optimal treatment possibilities.
PreCheck offers a range of genetic tests designed for various conditions. Each test comes with clear follow-up recommendations, enabling healthcare providers to make personalized decisions based on your genetic profile.
latest announcements and stay updated on our most recent developments.
.svg)
